Induction of apoptosis by a stilbene analog involves Bax translocation regulated by p38 MAPK and Akt

Archives of Pharmacal Research

Volumn 31, Issue 4, 2008, Pages 438-444

  So, Kwang Sup ^a   Oh, Ji Eun ^a   Han, Jee Hye ^a   Jung, Hong Keun ^a   Lee, Young Suk ^a   Kim, Sang Hee ^b   Chun, Young Jin ^a   Kim, Mie Young ^a  

^a Chung Ang University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Akt; Apoptosis; Bax; Cytochrome P450 1B1; p38 MAPK; Stilbene

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTINEOPLASTIC AGENT; BAD PROTEIN, HUMAN; BAX PROTEIN, HUMAN; CYP1B1 PROTEIN, HUMAN; CYTOCHROME C; CYTOCHROME P450; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; ONCOPROTEIN; PROTEIN BAD; PROTEIN BAX; STILBENE DERIVATIVE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL STRAIN HL 60; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; ENZYME REPRESSION; ENZYMOLOGY; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; MITOCHONDRION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TIME;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-ASSOCIATED DEATH PROTEIN; CELL SURVIVAL; CYTOCHROME P-450 ENZYME SYSTEM; CYTOCHROMES C; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME REPRESSION; HL-60 CELLS; HUMANS; MITOCHONDRIA; ONCOGENE PROTEIN V-AKT; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN TRANSPORT; RNA, MESSENGER; SIGNAL TRANSDUCTION; STILBENES; TETRACHLORODIBENZODIOXIN; TIME FACTORS; TRANSFECTION;

EID: 43049150747     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-001-1176-7     Document Type: Article

References (34)

1. Aggarwal. B. B., Resveratrol blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-κB inhibits proliferation, causes S-phase arrest and induces apoptosis of acute myeloid leukemia cells. Blood, 102, 987-995 (2003).
2. Anter, E., Thomas, S. R., Schulz, E., Shapira, O. M., Vita, J. A., and Jr. Keaney, J. F., Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. J. Biol. Chem., 279, 46637-46643 (2004).
3. Aziz, M. H., Kumar, R., and Ahmad, N., Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int. J. Oncol., 23, 17-28 (2003).
4. Aziz, M. H., Nihal, M., Fu, V. X., Jarrard, D. F., and Ahmad, N., Resveratrol-caused apoptosis of human prostate carcinoma LNCaP cells is mediated via modulation of phosphatidylinositol 3′-kinase/Akt pathway and Bcl-2 family proteins. Mol. Cancer Ther., 5, 1335-1341 (2006).
5. Chen, J.-H., Hurh, Y.-J., Na, H.-K., Kim, J.-H., Chun, Y.-J., Kim, D.-H., Kang, K.-S., Cho, M.-H., and Surh, Y.-J., Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells. Carcinogenesis, 25, 2005-2013 (2004).
6. Chang, L. and Karin, M., Mammalian MAP kinase signaling cascades. Nature, 410, 37-40 (2001).
7. Chun, Y.-J., Kim, S., Kim, D., Lee, S.-K., and Guengerich, F. P., A new selective and potent inhibitor of human cytochrome P450 1B1 and its application to antimutagenesis. Cancer Res., 61, 8164-8170 (2001).
8. Chun, Y-J., Lee, S-K., and Kim, M. Y., Modulation of human cytochrome P450 1B1 expression by 2,4,3′,5′-tetramethoxy-stilbene. Drug Metab. Dispos., 33, 1771-1776 (2005).
9. Ciolino, H. P., Daschner, P. J., and Yeh, G. C., Resveratol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor. Cancer Res., 58, 5707-5712 (1998).
10. Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, Y., Gotoh, Y., and Greenberg, M. E., Akt phospohorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231-241 (1997).
11. Estrav, Z., Shishodia, S., Van D., Harris, Q., Kantarjian, H. M., Talpaz, M., Tsuruta, F., Masuyama, N., and Gotoh, Y., The phosphatydilinositol 3-kinase (PI3)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem., 277, 14040-14047 (2002).
12. Finucane, D. M., Bossy-Wetzel, E., Waterhouse, N. J., Cotter, T. G., and Green, D. R., Bax-induced caspase activation and apoptosis via cytochrome c release from mitochondria is inhibitable by Bcl-xL. J. Biol. Chem., 274, 2225-2233 (1999).
13. Ghatan, S., Lamer, S., Kinoshta, Y., Helman, M., Patel, L., Xia, Z., R. J., Youle, R. J., and Morrison, R. S., p38 MAP kinase mediates Bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol., 150, 335-347 (2000).
14. Green, D. R. and Reed, J. C., Mitochondria and apoptosis. Science, 281, 1309-1312 (1998).
15. Gross, A., McDonnell, J. M., and Korsmeyer, S. J., Bcl-2 family members and the mitochondria in apoptosis. Genes & Dev., 13, 1899-1911 (1999).
16. Guengerich, F. P., Chun, Y.-J., Kim, D., Gillam, E. M. J., and Shimada, T., Cytochrome P450 1B1: a target for inhibition in anticarcinogenesis strategies. Mutat. Res., 523-4, 173-182 (2003).
17. Hayes, C. L., Spink, D. C., Spiink, B. C., Cap, J. Q., Walker, J. J., and Sutter, T. R., 17β-estradiol hydroxylation catalyzed by human cytochrome P450 1B1. Proc. Natl. Acad. Sci. U.S.A., 93, 9776-9781 (1996).
18. Jang, M., Cai, L., and Udeani, G. O., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science, 275, 218-220 (1997).
19. Kang, J. H. Park, Y. H., Choi, S. W., Yang, E. K., and Lee, W. J., Resveratrol derivatives potently induce apoptosis in human promyelocytic leukemia cells. Exp. Mol. Med., 35, 467-474 (2003).
20. Kennedy, S. G., Wagner, A. J., Conzen, S. D., Jordan, J., Bellacosa, A., Tsichlis, P. N., and Hay, N., The PI3-kinase/Akt signaling pathway delivers an anti-apoptotic signal. Genes Dev., 11 701-713 (1997).
21. Kim, D., Kim, S., Koh, H., S. Yoon, Chung, A., Cho, K. S., and Chung, J., Akt/PKB promotes cancer cell invasion via increased motility and metaaloproteinase production. FASEB J., 15, 1953-1962 (2001).
22. Kim, H. J., Kang, S. K., Mun, J. Y., Chun, Y. J., Choi, K. H., and Kim, M. Y., Involvement of Akt in mitochondria-dependent apoptosis induced by a cdc25 phosphatase inhibitor naphthoquinone analog. FEBS Lett., 555, 217-222 (2003).
23. Minutolo, F., Sala, G., Bagnacani, A., Bertin, S., Prota, G., Rapposelli, S., Sacchi, N., Macchia, M., and Ghidoni, R., Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells. J. Med. Chem., 48, 6783-6786 (2005).
24. Murray, G I., Taylor, M. C., McFadyen, M. C. E., McKay, J. A. Greenlee, W. F., Burke, M. D., and Melvin, W. T., Tumor specific expression of cytochrome P450 CYP1B1. Cancer Res., 57, 3026-3031 (1997).
25. Pervaiz, S., Resveratrol: from grapevines to mammalian biology. FASEB J., 17, 1975-1985 (2003).
26. Potter, G. A., Patterson, L. H., Wanogho, E., Perry, P. J., Butler, P. C., Ijaz, T., Ruparelia, K. C., Lamb, J. H., Farmer, P. B., Stanley, L. A., and Burke, M. D., The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1. Br. J. Cancer., 86, 774-778 (2002).
27. Scarlatti, F., Sala, G., Somenzi, G., Signorelli, P., Sacchi, N., and Ghidoni, R., Resveratrol induces growth inhibition and apoptosis in metastasis breast cancer cells via de novo ceramide signaling. FASEB J., 17, 2339-2341 (2003).
28. She, Q. B., Bode, A. M., Ma, W. Y., Chen, N. Y., and Dong, Z., Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase. Cancer Res., 61, 1604-1610 (2001).
29. Subbaramaiah, K., Chung W. J., Michaluart, P., Tanabe, T., Inoue, H., Jang, M., Pezzuto, J. M., and Dannenberg, A. J., Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells. J. Biol. Chem., 273, 21875-21882 (1998).
30. Sutter, T. R., Guzman, K., Dold, K. M., and Greenlee, W. F., Targets for dioxin: gene for plasminogen activator inhibitor-2 and interleukin-1. Science, 254, 415-418 (1991).
31. Testa, J. R. and Bellacosa, A., Akt plays a central role in tumorigenesis. Proc. Natl. Acad. Sci. U.S.A., 98, 10983-10985 (2001).
32. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J., Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3-not Bcl-XL. Cell., 87, 619-628 (1996).
33. Zhang, L., Yu, J., Park, B. H., Kinzler, K. W., and Vogelstein, B., Role of BAX in the apoptotic response to anticancer agents. Science, 290, 989-992 (2000).
34. Zhou, H., Li, X.-M., Meinkoth, J., and Pittman, R. N., Akt regulates cell survival and apoptosis at a postmitochondrial level. J. Cell Biol., 151, 483-494 (2000).